DR

Devendra Rao Bhomle

Active Director Director DIN 09836790
DIN 09836790 First appointment Dec 2022 Primary industry Jewelry & Fashion Accessories
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Devendra Rao Bhomle

Data last updated:

Devendra Rao Bhomle is a Director at Curenode Pharmaceuticals Private Limited (since 2022). The company operates in Jewelry & Fashion Accessories.

DIN 09836790
Primary Designation Director
Industry Jewelry & Fashion Accessories
First Appointment 26 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Dec 20222022Active

Board colleagues of Devendra Rao Bhomle

NameDINCompanyDesignation
Rakhi Kesharwani09836789Curenode Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curenode Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Devendra Rao Bhomle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devendra Rao Bhomle

Devendra Rao Bhomle currently holds 1 directorship: Curenode Pharmaceuticals Private Limited (Director, since 26 Dec 2022).

Devendra Rao Bhomle was first appointed on 26 Dec 2022 as Director at Curenode Pharmaceuticals Private Limited.

The current boards of Devendra Rao Bhomle's companies include Rakhi Kesharwani (Curenode Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available